protein kinase. Diabetes Obes Metab
15:1128–1135- Skrede S, Martins L, Berge RK, Steen VM,
Lopez M, Ferno J (2014) Olanzapine depot
formulation in rat: a step forward in modelling
antipsychotic-induced metabolic adverse
effects. Int J Neuropsychopharmacol
17:91–104 - He M, Zhang Q, Deng C, Wang H, Lian J,
Huang XF (2014) Hypothalamic histamine H1
receptor-AMPK signaling time-dependently
mediates olanzapine-induced hyperphagia and
weight gain in female rats. Psychoneuroendo-
crinology 42:153–164 - Breen DM, Sanli T, Giacca A, Tsiani E (2008)
Stimulation of muscle cell glucose uptake by
resveratrol through sirtuins and AMPK. Bio-
chem Biophys Res Commun 374:117–122 - Vingtdeux V, Giliberto L, Zhao H et al (2010)
AMP-activated protein kinase signaling activa-
tion by resveratrol modulates amyloid-beta
peptide metabolism. J Biol Chem
285:9100–9113 - Ahn J, Lee H, Kim S, Park J, Ha T (2008) The
anti-obesity effect of quercetin is mediated by
the AMPK and MAPK signaling pathways. Bio-
chem Biophys Res Commun 373:545–549 - Lu J, Wu DM, Zheng YL et al (2010) Querce-
tin activates AMP-activated protein kinase by
reducing PP2C expression protecting old
mouse brain against high cholesterol-induced
neurotoxicity. J Pathol 222:199–212 - Martı ́nez de Morentin PB, Gonza ́lez CR,
Lo ́pez M (2010) AMP-activated protein
kinase: ‘a cup of tea’ against cholesterol-
induced neurotoxicity. J Pathol 222:329–334 - Eid HM, Nachar A, Thong F, Sweeney G,
Haddad PS (2015) The molecular basis of the
antidiabetic action of quercetin in cultured
skeletal muscle cells and hepatocytes. Pharma-
cogn Mag 11:74–81 - Lo ́pez M, Tena-Sempere M (2017) Estradiol
effects on hypothalamic AMPK and BAT ther-
mogenesis: a gateway for obesity treatment?
Pharmacol Ther 178:109. https://doi.org/
10.1016/j.pharmthera.2017.03.014- Lo ́pez M (2017) EJE PRIZE 2017: hypotha-
lamic AMPK: a golden target against obesity?
Eur J Endocrinol 176:R235–R246 - Minokoshi Y, Kim YB, Peroni OD et al (2002)
Leptin stimulates fatty-acid oxidation by acti-
vating AMP-activated protein kinase. Nature
415:339–343 - Va ́zquez MJ, Gonza ́lez CR, Varela L et al
(2008) Central resistin regulates hypothalamic
and peripheral lipid metabolism in a
nutritional-dependent fashion. Endocrinology
149:4534–4543 - Ferno J, Varela L, Skrede S et al (2011)
Olanzapine-induced hyperphagia and weight
gain associate with orexigenic hypothalamic
neuropeptide signaling without concomitant
AMPK phosphorylation. PLoS One 6:e20571 - Sangiao-Alvarellos S, Varela L, Va ́zquez MJ
et al (2010) Influence of ghrelin and GH defi-
ciency on AMPK and hypothalamic lipid
metabolism. J Neuroendocrinol 22:543–556 - Velasquez DA, Martinez G, Romero A et al
(2011) The central Sirtuin 1/p53 pathway is
essential for the orexigenic action of ghrelin.
Diabetes 60:1177–1185 - Varela L, Martı ́nez-Sa ́nchez N, Gallego R et al
(2012) Hypothalamic mTOR pathway med-
iates thyroid hormone-induced hyperphagia in
hyperthyroidism. J Pathol 227:209–222 - Martinez de Morentin PB, Lage R, Gonzalez-
Garcia I et al (2015) Pregnancy induces resis-
tance to the anorectic effect of hypothalamic
malonyl-CoA and the thermogenic effect of
hypothalamic AMPK inhibition in female rats.
Endocrinology 156:947–960 - Bain J, Plater L, Elliott M et al (2007) The
selectivity of protein kinase inhibitors: a further
update. Biochem J 408:297–315 - Paxinos G, Watson C (eds) (1986) The rat
brain in stereotaxic coordinates. Academic
Press, Sydney
448 Patricia Seoane-Collazo and Miguel Lo ́pez